Generation of Standard Laboratory Values for Pneumococci Antibodies

The determination of reference values is a necessary basis for research and clinical routine testing for pneumococci antibodies

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Reference Values

Sex eligibility

All sexes

Study type

Observational

Primary location

Goethe University, Department of Pulmonology

Frankfurt am Main, Hesse, 60590, Germany

About this study

This study is meant to determine specific pneumococcal antibodies stratified for age. The investigators also correlate our assay with the results from a commercially available pneumococcal screening ELISA (iGG1 and IgG2) in order to facilitate a screening for immunodeficiency, and to monitor the success of a performed immunization

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects undergoing elective surgery

Exclusion criteria

Chronic illness condition,
Immunodeficiency

Treatment and study plan

Primary outcomes

sufficient samples to calculate reference values

Time frame: 10(2006-10/2007)

Secondary outcomes

sufficient samples to correlate with screening assay

Time frame: 10/2006-10/2007

Sponsors and collaborators

Lead sponsor

Johann Wolfgang Goethe University Hospital

Other

Registry information

Important dates

Study start: 2006
Primary completion: 2010
Study completion: 2010
First posted: Dec 5, 2007
Registry last updated: Jan 17, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed